<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0020387</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Infectious Diseases</subject>
          <subject>Biochemistry/Drug Discovery</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Drugs and adverse drug reactions</subject>
          <subject>Health Policy</subject>
          <subject>Infectious Diseases</subject>
          <subject>International health</subject>
          <subject>Medicine in Developing Countries</subject>
        </subj-group>
      </article-categories><title-group><article-title>The Need of a Neonatal Preparation for Chagas Disease</article-title><alt-title alt-title-type="running-head">Correspondence</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Sosa-Estani</surname>
            <given-names>Sergio</given-names>
          </name>
          <xref ref-type="corresp" rid="n1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Belizan</surname>
            <given-names>Jose M</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Althabe</surname>
            <given-names>Fernando</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Rubinstein</surname>
            <given-names>Aldofo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label>
				
				<addr-line>Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina</addr-line>
				
			</aff><author-notes>
        <corresp id="n1">E-mail: <email xlink:type="simple">ssosa@msal.gov.ar</email></corresp>
      <fn fn-type="conflict" id="n2">
        <p> The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>11</month>
        <year>2005</year>
      </pub-date><pub-date pub-type="epub">
        <day>29</day>
        <month>11</month>
        <year>2005</year>
      </pub-date><volume>2</volume><issue>11</issue><elocation-id>e387</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2005</copyright-year><copyright-holder>Sosa-Estani et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><related-article page="e210" related-article-type="companion" vol="2" xlink:href="info:doi/10.1371/journal.pmed.0020210" xlink:title="diseases" xlink:type="simple">
				<article-title>Designing Drugs for Parasitic Diseases of the Developing World</article-title>
			</related-article></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>We have read about the efforts and initiatives related to the design of drugs for parasitic diseases in McKerrow's article [<xref ref-type="bibr" rid="pmed-0020387-b1">1</xref>] with interest and expectation. One of the pressing needs in this area is for a neonatal preparation for Chagas disease.</p>
      <p>Satisfactory achievements have been made in Argentina in relation to the transmission of the disease by vectors and through blood transfusion [<xref ref-type="bibr" rid="pmed-0020387-b2">2</xref>,<xref ref-type="bibr" rid="pmed-0020387-b3">3</xref>]. Vertical transmission is now the great challenge in eradicating Chagas disease. Around 800–1,300 neonates infected with <named-content content-type="genus-species" xlink:type="simple">Trypanosmoma cruzi</named-content> are born every year in our country [<xref ref-type="bibr" rid="pmed-0020387-b4">4</xref>]. Almost 99% of all births occur in hospital, thus allowing the detection of infants born with parasites immediately after birth. The initiation of treatment of these neonates before they and their mothers leave the hospital is a good strategy to obtain high treatment coverage. The later attendance of mothers with their children to health-care facilities is quite unpredictable and irregular. Also, it is difficult to link information about maternal and neonatal parasitic status obtained at birth with later attendance at other health-care facilities.</p>
      <p>It would, therefore, be of great value to have a neonatal preparation for the treatment of Chagas disease. There is currently no neonatal or infant preparation available. Instead, one of the two available adult preparations (nifurtimox or benznidazol) is mashed and diluted at local level in order to be administered to newborns and infants. It is easy to understand the difficulties and uncertainties that these procedures involve.</p>
      <p>We hope that in the agenda of the several initiatives mentioned in this article [<xref ref-type="bibr" rid="pmed-0020387-b1">1</xref>] the development of a neonatal preparation for Chagas disease could be considered. It would benefit many infants every year.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pmed-0020387-b1">
        <label>1</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>McKerrow</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Designing drugs for parasitic diseases of the developing world.</article-title>
          <source>PLoS Med</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>e210</fpage>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0020210" xlink:type="simple">10.1371/journal.pmed.0020210</ext-link></comment>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020387-b2">
        <label>2</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Segura</surname>
              <given-names>EL</given-names>
            </name>
            <name name-style="western">
              <surname>Cura</surname>
              <given-names>EN</given-names>
            </name>
            <name name-style="western">
              <surname>Sosa Estani</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Andrade</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Lansetti</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long-term effects of a Nation-wide control program on the seropositivity for <named-content content-type="genus-species" xlink:type="simple">Trypanosoma cruzi</named-content> infection in young men from Argentina.</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2000</year>
          <volume>62</volume>
          <fpage>353</fpage>
          <lpage>362</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020387-b3">
        <label>3</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Segura</surname>
              <given-names>EL</given-names>
            </name>
            <name name-style="western">
              <surname>Esquivel</surname>
              <given-names>ML</given-names>
            </name>
            <name name-style="western">
              <surname>Salomón</surname>
              <given-names>O</given-names>
            </name>
            <name name-style="western">
              <surname>Gómez</surname>
              <given-names>AO</given-names>
            </name>
            <name name-style="western">
              <surname>Sosa Estani</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Participación comunitaria en el Programa Nacional de Control de la Transmisión de la Enfermedad de Chagas.</article-title>
          <source>Medicina (B Aires)</source>
          <year>1994</year>
          <volume>54</volume>
          <fpage>610</fpage>
          <lpage>611</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020387-b4">
        <label>4</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gurtler</surname>
              <given-names>RE</given-names>
            </name>
            <name name-style="western">
              <surname>Segura</surname>
              <given-names>EL</given-names>
            </name>
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Congenital transmission of <named-content content-type="genus-species" xlink:type="simple">Trypanososma cruzi</named-content> infection in Argentina.</article-title>
          <source>Emerg Infect Dis</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>29</fpage>
          <lpage>32</lpage>
        </nlm-citation>
      </ref>
    </ref-list>
    
  </back>
</article>